0      0

JL1132C - JL1132C: Utility of the MammaPrint 70-gene and BluePrint-80 gene expression signatures in providing personalized treatment decision in early-stage breast cancer, and the role of the Advanced Practice Provider: A Case Study Approach

Victoria Poillucci,1 DNP, MEd, ACNP-BC, Dudmire Belizaire,2 FNP-BC, Tara Ackerly,3 APRN-BC, Christina Z. Page1, AGPCNP-BC®, AOCNP®

1Agendia, 2Kings County Hospital Center, 3Trinity Health of New England


You must be logged in and own this session in order to post comments.